Background
Cigarette smoking is the lea
ding cause of preventable
death in the worl
d, an
d long-term abstinence rates remain mo
dest. Min
dfulness training (MT) has begun to show benefits in a number of psychiatric
disor
ders, inclu
ding
depression, anxiety an
d more recently, in a
ddictions. However, MT has not been evaluate
d for smoking cessation through ran
domize
d clinical trials.
Methods
88 treatment-seeking, nicotine-dependent adults who were smoking an average of 20 cigarettes/day were randomly assigned to receive MT or the American Lung Association's freedom from smoking (FFS) treatment. Both treatments were delivered twice weekly over 4 weeks (eight sessions total) in a group format. The primary outcomes were expired-air carbon monoxide-confirmed 7-day point prevalence abstinence and number of cigarettes/day at the end of the 4-week treatment and at a follow-up interview at week 17.
Results
88 % of individuals received MT and 84 % of individuals received FFS completed treatment. Compared to those randomized to the FFS intervention, individuals who received MT showed a greater rate of reduction in cigarette use during treatment and maintained these gains during follow-up (F = 11.11, p = .001). They also exhibited a trend toward greater point prevalence abstinence rate at the end of treatment (36 % vs. 15 % , p = .063), which was significant at the 17-week follow-up (31 % vs. 6 % , p = .012).
Conclusions
This initial trial of mindfulness training may confer benefits greater than those associated with current standard treatments for smoking cessation.